Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP923496.RARS-cFZP-hMK1XTWFAuWhGM3339cSpZusEZCeFeWpldc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP923496.RARS-cFZP-hMK1XTWFAuWhGM3339cSpZusEZCeFeWpldc130_assertion type Assertion NP923496.RARS-cFZP-hMK1XTWFAuWhGM3339cSpZusEZCeFeWpldc130_head.
- NP923496.RARS-cFZP-hMK1XTWFAuWhGM3339cSpZusEZCeFeWpldc130_assertion wasGeneratedBy ECO_0000203 NP923496.RARS-cFZP-hMK1XTWFAuWhGM3339cSpZusEZCeFeWpldc130_provenance.
- NP923496.RARS-cFZP-hMK1XTWFAuWhGM3339cSpZusEZCeFeWpldc130_assertion wasDerivedFrom befree-20140225 NP923496.RARS-cFZP-hMK1XTWFAuWhGM3339cSpZusEZCeFeWpldc130_provenance.
- NP923496.RARS-cFZP-hMK1XTWFAuWhGM3339cSpZusEZCeFeWpldc130_assertion SIO_000772 16435073 NP923496.RARS-cFZP-hMK1XTWFAuWhGM3339cSpZusEZCeFeWpldc130_provenance.
- NP923496.RARS-cFZP-hMK1XTWFAuWhGM3339cSpZusEZCeFeWpldc130_assertion evidence source_evidence_literature NP923496.RARS-cFZP-hMK1XTWFAuWhGM3339cSpZusEZCeFeWpldc130_provenance.
- NP923496.RARS-cFZP-hMK1XTWFAuWhGM3339cSpZusEZCeFeWpldc130_assertion description "[Further analysis of primary tumors indicated that the frequency of hypermethylation was high for ASC (82%) and PAX3 (86%) in all tumor types, and high for RIPK3 in small cell carcinoma (57%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP923496.RARS-cFZP-hMK1XTWFAuWhGM3339cSpZusEZCeFeWpldc130_provenance.